Human Papillomavirus Assays and Cytology in Primary Cervical Screening of Women Aged 30 Years and Above.
about
HPV Prevalence in the Dutch cervical cancer screening population (DuSC study): HPV testing using automated HC2, cobas and Aptima workflowsThe BD Onclarity HPV Assay on Samples Collected in SurePath Medium Meets the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening.Differential Detection of Human Papillomavirus Genotypes and Cervical Intraepithelial Neoplasia by Four Commercial Assays.Performance of mRNA- and DNA-based high-risk human papillomavirus assays in detection of high-grade cervical lesions.Referral population studies underestimate differences between human papillomavirus assays in primary cervical screening.Prevalence of Human Papillomavirus in Self-Taken Samples from Screening Nonattenders.High-grade cervical intraepithelial neoplasia in human papillomavirus self-sampling of screening non-attenders.Cervical cancer screening cotesting with cytology and MRNA HPV E6/E7 yields high rates of CIN2+ lesions in young women.Performance of Aptima and Cobas HPV testing platforms in detecting high-grade cervical dysplasia and cancer.Comparative accuracy of Pap smear and HPV screening in Ubon Ratchathani in Thailand.Preventing cervical cancer using HPV self-sampling: direct mailing of test-kits increases screening participation more than timely opt-in procedures - a randomized controlled trial.
P2860
Q36205998-4B444B41-99A2-453F-B5E7-C9A2AB71ACFEQ37218627-B0FAE189-411C-4A97-93D8-8922DA9AA6ECQ37363392-72A0C2C5-C1D1-4556-A95B-B34A3B4FC350Q39177983-E9DB5A6E-DB14-4C5C-9307-D5EC10217C6FQ40043990-4366DD7B-B98F-4D0C-806B-92227909E1B1Q40116201-80EDBCFF-644C-42C9-8572-E29D71360BC4Q47580645-7C4296A8-6616-48BA-89DD-6990938E6BCEQ47631015-81AEE1C4-551F-41C0-A8C2-FA347EC7F593Q48336018-6EBAE09D-5A6A-4ADB-B31D-BF4FEF81656EQ55315566-14857CBC-730A-42C7-ADF5-89A7F3303736Q55409918-7209319F-63EC-498A-9D36-57971EF3FCA6
P2860
Human Papillomavirus Assays and Cytology in Primary Cervical Screening of Women Aged 30 Years and Above.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Human Papillomavirus Assays an ...... Women Aged 30 Years and Above.
@ast
Human Papillomavirus Assays an ...... Women Aged 30 Years and Above.
@en
type
label
Human Papillomavirus Assays an ...... Women Aged 30 Years and Above.
@ast
Human Papillomavirus Assays an ...... Women Aged 30 Years and Above.
@en
prefLabel
Human Papillomavirus Assays an ...... Women Aged 30 Years and Above.
@ast
Human Papillomavirus Assays an ...... Women Aged 30 Years and Above.
@en
P2093
P2860
P50
P1433
P1476
Human Papillomavirus Assays an ...... Women Aged 30 Years and Above.
@en
P2093
Carsten Rygaard
Ditte Ejegod
Sarah Preisler
P2860
P304
P356
10.1371/JOURNAL.PONE.0147326
P407
P577
2016-01-20T00:00:00Z